Novavax (NVAX) Misses Q2 Earnings and Revenue Estimates

Novavax (NVAX) came out with quarterly earnings of $0.99 per share, missing the Zacks Consensus Estimate of$ 1.82 per share. This compares to earnings of $0.58 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -45.60%. A quarter ago, it was expected that this vaccine maker would post a loss of$ 1.04 per share when it actually produced a loss of $1.05, delivering a surprise of -0.96%. Over the last four quarters, the company has ...